vTv Therapeutics (VTVT) Market Capitalization (2015 - 2026)

vTv Therapeutics has disclosed Market Capitalization across 12 years of filings, most recently posting $467.2 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 372.86% year-over-year to $467.2 million; the TTM figure through Jun 2026 stood at $467.2 million (up 372.86% YoY), while the FY2025 annual figure was $336.9 million, up 322.7% from the prior year.
• Market Capitalization came in at $467.2 million for Q2 2026 at vTv Therapeutics, down from $492.2 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $492.2 million in Q1 2026 to a low of $30.6 million in Q4 2023.
• Average Market Capitalization over 5 years is $145.3 million, with a median of $91.0 million recorded in 2023.
• Year-over-year, Market Capitalization plunged 71.42% in 2022 and soared 372.86% in 2026.
• Over 5 years, Market Capitalization stood at $69.3 million in 2022, then tumbled by 55.83% to $30.6 million in 2023, then soared by 160.29% to $79.7 million in 2024, then soared by 322.7% to $336.9 million in 2025, then soared by 38.7% to $467.2 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $467.2 million in Q2 2026, $492.2 million in Q1 2026, and $336.9 million in Q4 2025.